Deoxycholic Acid Injection for the Treatment of Superficial Lipomas

Completed · Phase 1 · Has a placebo group

Conditions studied: Lipoma

In brief

The purpose of this research is to compare the safety and effectiveness of 4 different concentrations of deoxycholic acid injection against a placebo in the treatment of superficial lipomas.

Key facts

Study ID

NCT00422188

Run by

Kythera Biopharmaceuticals

People needed

16

Starts

2007-01-01

Expected to finish

2007-11-01

Last updated by the study team

2015-12-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• One or more lipomas, based on clinical diagnosis, which are accessible for treatment and assessment, are quantifiable along at least 2 perpendicular diameters, and have the following characteristics:
• History of slow growth followed by dormancy, and stable for at least 6 months.
• Greatest length by greatest perpendicular width between 1 and 16 square centimeters, inclusive
• Discrete, oval to rounded in shape, not hard or attached to underlying tissue
• Located on the trunk, arms, legs, or neck
• Stable body weight with a body mass index of less than 30 kg/m²
• Signed informed consent

You may not qualify if…

• Absence of significant medical conditions that could affect safety
• History of surgical treatment for lipomas
• Treatment with an investigational agent within 30 days before ATX-101 treatment

Where it is running

• Therapeutics Clinical Research — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.